These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 17226071)
41. Interaction of cyclooxygenase-2 inhibitors and salicylate in gastric mucosal damage. Peskar BM; Ehrlich K; Peskar BA Eur J Pharmacol; 2002 Jan; 434(1-2):65-70. PubMed ID: 11755167 [TBL] [Abstract][Full Text] [Related]
42. Pharmacological profile of celecoxib, a specific cyclooxygenase-2 inhibitor. Yoshino T; Kimoto A; Kobayashi S; Noguchi M; Fukunaga M; Hayashi A; Miyata K; Sasamata M Arzneimittelforschung; 2005; 55(7):394-402. PubMed ID: 16080279 [TBL] [Abstract][Full Text] [Related]
43. Effects of aminoguanidine and cyclooxygenase inhibitors on nitric oxide and prostaglandin production, and nitric oxide synthase and cyclooxygenase expression induced by lipopolysaccharide in the estrogenized rat uterus. Ribeiro M; Cella M; Farina M; Franchi A Neuroimmunomodulation; 2004; 11(3):191-8. PubMed ID: 15067210 [TBL] [Abstract][Full Text] [Related]
44. Cholecystokinin secretagogue-induced gastroprotection: role of nitric oxide and blood flow. West SD; Helmer KS; Chang LK; Cui Y; Greeley GH; Mercer DW Am J Physiol Gastrointest Liver Physiol; 2003 Mar; 284(3):G399-410. PubMed ID: 12444009 [TBL] [Abstract][Full Text] [Related]
45. Role of prostaglandins in gastroprotection and gastric adaptation. Brzozowski T; Konturek PC; Konturek SJ; Brzozowska I; Pawlik T J Physiol Pharmacol; 2005 Sep; 56 Suppl 5():33-55. PubMed ID: 16247188 [TBL] [Abstract][Full Text] [Related]
46. Aspirin, but not NO-releasing aspirin (NCX-4016), interacts with selective COX-2 inhibitors to aggravate gastric damage and inflammation. Wallace JL; Zamuner SR; McKnight W; Dicay M; Mencarelli A; del Soldato P; Fiorucci S Am J Physiol Gastrointest Liver Physiol; 2004 Jan; 286(1):G76-81. PubMed ID: 14665439 [TBL] [Abstract][Full Text] [Related]
47. Protective effects of friedelin isolated from Azima tetracantha Lam. against ethanol-induced gastric ulcer in rats and possible underlying mechanisms. Antonisamy P; Duraipandiyan V; Aravinthan A; Al-Dhabi NA; Ignacimuthu S; Choi KC; Kim JH Eur J Pharmacol; 2015 Mar; 750():167-75. PubMed ID: 25617794 [TBL] [Abstract][Full Text] [Related]
48. [Effects of cyclooxygenase-2 on formation and healing of acetic acid-induced gastric ulcer in rats]. Shen X Zhonghua Yi Xue Za Zhi; 2001 Nov; 81(22):1380-3. PubMed ID: 11930633 [TBL] [Abstract][Full Text] [Related]
49. Roles of endogenous prostaglandins and cyclooxygenase izoenzymes in mucosal defense of inflamed rat stomach. Takeeda M; Hayashi Y; Yamato M; Murakami M; Takeuchi K J Physiol Pharmacol; 2004 Mar; 55(1 Pt 2):193-205. PubMed ID: 15082878 [TBL] [Abstract][Full Text] [Related]
50. Comparison of antinociceptive efficacy and gastroprotection between celecoxib and diclofenac plus misoprostol in rats. Reyes-García G; Déciga-Campos M; Medina-Santillan R; Granados-Soto V Proc West Pharmacol Soc; 2007; 50():69-71. PubMed ID: 18605234 [TBL] [Abstract][Full Text] [Related]
51. Rofecoxib produces intestinal but not gastric damage in the presence of a low dose of indomethacin in rats. Yokota A; Taniguchi M; Takahira Y; Tanaka A; Takeuchi K J Pharmacol Exp Ther; 2005 Jul; 314(1):302-9. PubMed ID: 15831440 [TBL] [Abstract][Full Text] [Related]
52. Chemopreventive properties of a selective inducible nitric oxide synthase inhibitor in colon carcinogenesis, administered alone or in combination with celecoxib, a selective cyclooxygenase-2 inhibitor. Rao CV; Indranie C; Simi B; Manning PT; Connor JR; Reddy BS Cancer Res; 2002 Jan; 62(1):165-70. PubMed ID: 11782374 [TBL] [Abstract][Full Text] [Related]
53. Mucosal damage induced by preferential COX-1 and COX-2 inhibitors: role of prostaglandins and inflammatory response. Villegas I; La Casa C; de la Lastra CA; Motilva V; Herrerías JM; Martín MJ Life Sci; 2004 Jan; 74(7):873-84. PubMed ID: 14659976 [TBL] [Abstract][Full Text] [Related]